Enhanced TDS
Identification & Functionality
- Chemical Name
- Technologies
- Product Families
- Definition
Bacitracin is a mixture of polypeptides produced by the growth of an organism of the licheniformis group of Bacillus subtilis (Fam. Bacillacaea), the main components being bacitracins A, B1, B2, and B3. It has a potency of not less than 65 Bacitracin units/mg, calculated on the dried basis.Bacitracin is a mixture of polypeptides produced by the growth of an organism of the licheniformis group of Bacillus subtilis (Fam. Bacillacaea), the main components being bacitracins A, B1, B2, and B3. It has a potency of not less than 65 Bacitracin units/mg, calculated on the dried basis.
- Chemical Structure
Applications & Uses
Regulatory & Compliance
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- USP Reference Standards
- USP Bacitracin Zinc RS (CN 1-May-2018)
Packaging & Availability
- Labelling Information
Where it is packaged for prescription compounding, label it to indicate that it is not sterile and that the potency cannot be assured for longer than 60 days after opening, and to state the number of Bacitracin Units/ mg. Where Bacitracin must be subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. 2S (USP41) Change to read